Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza Vaccine”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Early research (Phase 1)Study completedNCT00516035
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Large-scale testing (Phase 3)Ended earlyNCT00979667
What this trial is testing

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Who this might be right for
Upper Respiratory Tract InfectionInfluenza
Chinese University of Hong Kong 4
Early research (Phase 1)Study completedNCT01674205
What this trial is testing

Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Study completedNCT01000831
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

Who this might be right for
Influenza
University of British Columbia 167
Post-approval studies (Phase 4)Study completedNCT02133781
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

Who this might be right for
Influenza
Stanford University 51
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Testing effectiveness (Phase 2)Study completedNCT01336166
What this trial is testing

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 480
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Not applicableStudy completedNCT01282177
What this trial is testing

Influenza Vaccine Safety and Effectiveness in Healthcare Providers

Who this might be right for
Influenza
Dalhousie University 1,143
Testing effectiveness (Phase 2)Study completedNCT01001169
What this trial is testing

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00959465
What this trial is testing

A/H1N1 Immunogenicity and Safety in Adults

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 408
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Early research (Phase 1)Study completedNCT00709800
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle)

Who this might be right for
Influenza
Vical 56
Early research (Phase 1)Study completedNCT00380237
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Not applicableStudy completedNCT01032980
What this trial is testing

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Who this might be right for
InfluenzaSwine-Origin A/H1N1 Influenza Virus
Sanofi Pasteur, a Sanofi Company 3,934
Testing effectiveness (Phase 2)Study completedNCT00695669
What this trial is testing

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Who this might be right for
Influenza
GlaxoSmithKline 312
Testing effectiveness (Phase 2)Study completedNCT00491985
What this trial is testing

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsInfluenza A Virus Infection
Sanofi Pasteur, a Sanofi Company 240
Load More Results